Abstract

PurposeFinancial toxicity can have a major impact on the quality of life of cancer survivors but lacks conceptual clarity and understanding of the interrelationships of the various aspects that constitute financial toxicity. This study aims to extract major drivers and mediators along the pathway from cancer-related costs to subjective financial distress from the patients’ experiences to establish a better understanding of financial toxicity as a patient-reported outcome.MethodsQualitative semistructured interviews with 39 cancer patients were conducted in Germany and addressed patient experiences with cancer-related financial burden and distress in a country with a statutory health care system. Transcripts were analyzed using content analysis.ResultsSeveral aspects of financial burden need to be considered to understand financial toxicity. The assessment of the ability to make ends meet now or in the future and the subjective evaluation of financial adjustments—namely, the burden of applied financial adjustments and the availability of financial adjustment options—mediate the connection between higher costs and subjective financial distress. Moreover, bureaucracy can influence financial distress through a feeling of helplessness during interactions with authorities because of high effort, non-traceable decisions, or one’s own lack of knowledge.ConclusionWe identified four factors that mediate the impact of higher costs on financial distress that should be addressed in further studies and targeted by changes in policies and support measures. Financial toxicity is more complex than previously thought and should be conceptualized and understood more comprehensively in measurements, including the subjective assessment of available adjustment options and perceived burden of financial adjustments.

Highlights

  • The costs due to a cancer diagnosis can have a major impact on treatment and patient outcomes

  • We chose a qualitative design with cancer survivors to capture potential mediators of the relationship between objective financial burden and subjective financial distress

  • Comparing 12 financially distressed and 22 low-stress cancer patients, we derived four main distressing factors that patients can feel exposed to and that may cause subjective financial distress

Read more

Summary

Introduction

The costs due to a cancer diagnosis can have a major impact on treatment and patient outcomes. Even though a unified understanding and measurement of FT is lacking [3], there is consensus on the clear distinction between objective financial burden attributable to cancer and related subjective financial distress [1, 4, 5]. Objective financial burden is often measured as the increase in individual costs. Measurement of subjective financial distress often includes material, psychosocial, and behavioural aspects [6]. Our understanding of FT is mainly based on quantitative studies analyzing the prevalence of or risk factors for any measure (objective or subjective) or the associations between measures and patient outcomes. The present work defines FT as the mechanism by which the objective burden

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call